138 related articles for article (PubMed ID: 15356424)
1. [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge.
Pinborg LH; Adams KH; Yndgaard S; Hasselbalch SG; Holm S; Kristiansen H; Paulson OB; Knudsen GM
J Cereb Blood Flow Metab; 2004 Sep; 24(9):1037-45. PubMed ID: 15356424
[TBL] [Abstract][Full Text] [Related]
2. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
[TBL] [Abstract][Full Text] [Related]
3. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Wingen M; Kuypers KP; Ramaekers JG
J Psychopharmacol; 2007 Jul; 21(5):477-85. PubMed ID: 17092965
[TBL] [Abstract][Full Text] [Related]
4. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
[TBL] [Abstract][Full Text] [Related]
6. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
[TBL] [Abstract][Full Text] [Related]
7. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX
Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132
[TBL] [Abstract][Full Text] [Related]
8. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
[TBL] [Abstract][Full Text] [Related]
10. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M
Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
[TBL] [Abstract][Full Text] [Related]
13. Measuring endogenous changes in serotonergic neurotransmission with [
da Cunha-Bang S; Ettrup A; Mc Mahon B; Skibsted AP; Schain M; Lehel S; Dyssegaard A; Jørgensen LM; Møller K; Gillings N; Svarer C; Knudsen GM
Transl Psychiatry; 2019 Apr; 9(1):134. PubMed ID: 30975977
[TBL] [Abstract][Full Text] [Related]
14. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
[TBL] [Abstract][Full Text] [Related]
15. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
Arborelius L; Linnér L; Wallsten C; Ahlenius S; Svensson TH
Psychopharmacology (Berl); 2000 Jul; 151(1):77-84. PubMed ID: 10958120
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
[TBL] [Abstract][Full Text] [Related]
17. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
[TBL] [Abstract][Full Text] [Related]
18. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Wingen M; Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
[TBL] [Abstract][Full Text] [Related]
19. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
Udo de Haes JI; Cremers TI; Bosker FJ; Postema F; Tiemersma-Wegman TD; den Boer JA
Neuropsychopharmacology; 2005 Sep; 30(9):1624-31. PubMed ID: 15827572
[TBL] [Abstract][Full Text] [Related]
20. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
Larisch R; Klimke A; Hamacher K; Henning U; Estalji S; Hohlfeld T; Vosberg H; Tosch M; Gaebel W; Coenen HH; Müller-Gärtner HW
Behav Brain Res; 2003 Feb; 139(1-2):21-9. PubMed ID: 12642173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
